Material Type

• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Other (1)
• Pathogen DNA (Derivative) (1)
• Plasma (single spun) (1)
• Saliva (1)
• Serum (2)
• Solid tissue (non viable) (1)
• Stool (2)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Affected (2)
• Not applicable (3)

Storage Temperature

• RT (1)
• -35°C to -18°C (2)
• -85°C to -60°C (4)

Associated Data

• Clinical records (3)
• Followup records (2)
• Freezer temperature logs (2)
• Genomic datasets (2)
• Microbiological results (1)
• Participant Ethnicity (2)
• Pre-analytical data (2)
• Survey data (2)
• Treatment records (3)

Timeframe

• Immediate (2)
• 0 - 3 months (4)
• 3 - 6 months (1)
• > 6 months (5)

Participant Count

• 11 - 100 (5)

Sex

• Male (1)
• Female (1)
• Both sexes (4)

Age Range

• Neonate (0 - 1 month) (1)
• Infant (1 month - 2 years) (1)
• Young child (2 - 6 years) (1)
• Child (6 - 12 years) (1)
• Adolescent (12 - 18 years) (2)
• Young adult (18 - 40 years) (1)
• Adult (> 40 years) (2)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Digital imaging (1)
• Infectious strain isolation (1)
• Molecular Extractions (1)
• Nucleic acid extraction (2)

Collection Type

• Cross-sectional (2)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (5)
• No Export restriction (4)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (3)
• No restrictions (0)
• No Project specific restriction (4)
• No Scope of use restriction (3)

Collection Status

• Completed (2)
• In progress (3)

Access Condition

• Open to applicants (1)
• Open in response to specific calls (1)
• Open only through collaboration (2)
• Data access only (1)

Country

• India (1)
• Peru (1)
• Spain (1)
• Switzerland (1)
• Uganda (1)

County